HeartSciences' MyoVista Insights Platform Endorsed by Cibolo Health for 123 Independent Hospitals
ByAinvest
Thursday, Jan 29, 2026 8:33 am ET1min read
HSCS--
HeartSciences' MyoVista Insights has been designated as the endorsed ECG management platform for Cibolo Health's network of 123 independent hospitals across six states. This collaboration aims to improve workflow efficiency, data accessibility, and clinical decision-making through a modern, cloud-native ECG management platform. The partnership will enable member hospitals to modernize legacy ECG workflows and support the integration of regulatory-compliant AI-ECG algorithms into routine clinical practice.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet